METABOLOMICS SERVICES MARKET ANALYSIS

Metabolomics Services Market, By Type of Technique (Detection Techniques, Separation Techniques), By Type of Service (Targeted Metabolomics, Untargeted Metabolomics, Metabolite Profiling, Biomarker Discovery, and Other Services), By Application (Drug Discovery, Toxicology Testing, Biomarker Discovery, Nutritional Research, Disease Diagnosis, and Other Applications), By End User (Academic and Research Institutes and Pharmaceutical and Biotechnology Companies, Contract Research Organizations (CROs), Diagnostic Laboratories, and Others), By Geography (North America, Latin America, Asia Pacific, Europe, Middle East, and Africa)

The global metabolomics services market is expected to witness significant growth over the forecast period driven by increasing R&D investment in drug discovery and development. The growing adoption of metabolomics approach for biomarker identification is further expected to propel the market growth. Additionally, rising prevalence of chronic and infectious diseases will fuel the demand for metabolomics services from pharmaceutical and biotechnology companies.
However, the market growth can be restrained by the high capital investment required for establishing metabolomics core facilities. Also, shortage of skilled professionals and lack of advanced infrastructure in emerging markets poses a challenge.
The North America region currently dominates the market and is expected to continue its dominance led by well-established biotech industry and major metabolomics services providers in the U.S. However, the Asia Pacific region is likely to witness the highest growth owing to rising healthcare expenditure, growing biomedical industry, and increasing R&D investments by market players looking to tap the opportunities in emerging Asian countries.
Metagenomics application area is anticipated to register fastest growth over the forecast period. Metabolomics is increasingly being utilized in metagenomics research for studying microbial metabolites and interactions, which will boost the metabolomics services adoption.